UG 📈 United-Guardian - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9105711082
UG: Cosmetics, Pharmaceuticals, Medical Lubricants, Industrial Products
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York. Web URL: https://www.u-g.com
Additional Sources for UG Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
UG Stock Overview
Market Cap in USD | 45m |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
GiC Sub-Industry | Personal Care Products |
IPO / Inception | 1992-03-17 |
UG Stock Ratings
Growth 5y | -26.9% |
Fundamental | 54.9% |
Dividend | 29.3% |
Rel. Strength Industry | 91.7 |
Analysts | - |
Fair Price Momentum | 9.53 USD |
Fair Price DCF | 23.16 USD |
UG Dividends
Dividend Yield 12m | 6.20% |
Yield on Cost 5y | 3.86% |
Annual Growth 5y | -38.10% |
Payout Consistency | 89.9% |
UG Growth Ratios
Growth Correlation 3m | -88.7% |
Growth Correlation 12m | 83.2% |
Growth Correlation 5y | -47.2% |
CAGR 5y | -9.04% |
CAGR/Mean DD 5y | -0.23 |
Sharpe Ratio 12m | 0.71 |
Alpha | 14.46 |
Beta | 0.58 |
Volatility | 40.70% |
Current Volume | 12.7k |
Average Volume 20d | 12.3k |
What is the price of UG stocks?
As of December 22, 2024, the stock is trading at USD 9.68 with a total of 12,664 shares traded.
Over the past week, the price has changed by -0.81%, over one month by -2.70%, over three months by -33.01% and over the past year by +25.98%.
As of December 22, 2024, the stock is trading at USD 9.68 with a total of 12,664 shares traded.
Over the past week, the price has changed by -0.81%, over one month by -2.70%, over three months by -33.01% and over the past year by +25.98%.
Is United-Guardian a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, United-Guardian (NASDAQ:UG) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 54.85 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UG as of December 2024 is 9.53. This means that UG is currently overvalued and has a potential downside of -1.55%.
Partly, yes. Based on ValueRay Fundamental Analyses, United-Guardian (NASDAQ:UG) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 54.85 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UG as of December 2024 is 9.53. This means that UG is currently overvalued and has a potential downside of -1.55%.
Is UG a buy, sell or hold?
United-Guardian has no consensus analysts rating.
United-Guardian has no consensus analysts rating.
What are the forecast for UG stock price target?
According to ValueRays Forecast Model, UG United-Guardian will be worth about 10.4 in December 2025. The stock is currently trading at 9.68. This means that the stock has a potential upside of +7.13%.
According to ValueRays Forecast Model, UG United-Guardian will be worth about 10.4 in December 2025. The stock is currently trading at 9.68. This means that the stock has a potential upside of +7.13%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 10.4 | 7.1% |